[SCHEDULE 13D/A] BlackRock Technology and Private Equity Term Trust SEC Filing

Rhea-AI Filing Summary

NanoVibronix, Inc. (NASDAQ: NAOV) filed an 8-K to disclose that its 11 July 2025 Special Meeting of Stockholders was opened and immediately adjourned for lack of a quorum. In accordance with the company’s bylaws, no business was conducted. The meeting will reconvene virtually on 17 July 2025 at 10:00 a.m. ET via www.virtualshareholdermeeting.com/NAOV2025SM2. The record date remains 16 May 2025, and the new proxy voting deadline for registered holders is 11:59 p.m. ET on 16 July 2025. Proxies already submitted remain valid; shareholders who have not yet voted may do so before the new deadline or during the reconvened meeting. The company refers investors to its Definitive Proxy Statement filed 20 June 2025 for further details and reminds investors that directors and officers may be deemed solicitation participants. No other corporate actions or financial results were reported in this filing.

Positive

• None.

Negative

• Adjournment for lack of quorum may signal weak shareholder engagement and could delay approval of time-sensitive proposals.

Insights

Corporate Governance Expert

TL;DR—Adjourned meeting signals low shareholder engagement; minimal direct financial impact.

The adjournment for lack of quorum highlights potential shareholder apathy or logistical issues. While not uncommon for micro-cap firms, repeated quorum failures can delay corporate actions and raise governance concerns. Reconvening within six days limits disruption, and proxy votes already cast remain valid, reducing administrative costs. Overall, this event is procedural with negligible near-term financial impact, but management should improve outreach to avoid future delays.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 25)

BlackRock Technology and Private Equity Term Trust

(Name of Issuer)

Common Shares, $0.001 par value

(Title of Class of Securities)

09260Q108

(CUSIP Number)

Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor, Attention: Michael D'Angelo
New York, NY, 10174
(212) 542-4635

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

07/09/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 09260Q108

1

Name of reporting person

Saba Capital Management, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN, IA

SCHEDULE 13D

CUSIP No. 09260Q108

1

Name of reporting person

Boaz R. Weinstein

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP No. 09260Q108

1

Name of reporting person

Saba Capital Management GP, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Shares, $0.001 par value
(b)	Name of Issuer: BlackRock Technology and Private Equity Term Trust
(c)	Address of Issuer's Principal Executive Offices: 50 Hudson Yards, New York, NEW YORK , 10001.
Item 1 Comment: This Amendment No. 25 amends Items 4 and 5.
Item 2.	Identity and Background
(a)	This Schedule 13D/A is being jointly filed by: (i) Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"); (ii) Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"); and (iii) Mr. Boaz R. Weinstein ("Mr. Weinstein"), (together, the "Reporting Persons"). Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Sections 13 of the Securities Exchange Act of 1934, the beneficial owner of the Common Shares reported herein.
(b)	The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.
(c)	The principal business of: (i) Saba Capital is to serve as investment manager to private and public investment funds and/or accounts, (ii) Saba GP is to serve as general partner of the Saba Capital and other affiliated entities, and (iii) Mr. Weinstein, an individual, is managing member of the general partner of Saba Capital and other affiliated entities.
(d)	The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	The Reporting Persons have not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.
(f)	Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.
Item 3.	Source and Amount of Funds or Other Consideration
	Not Applicable.
Item 4.	Purpose of Transaction
	On July 9, 2025, the Reporting Persons tendered into the Issuer's tender offer and the Issuer accepted 60,675,395 Common Shares in exchange for cash at a price of $7.4924 per share, as further described in the Current Report on Form 8-K filed by the Issuer on July 10, 2025. As a result, the Reporting Persons no longer own, beneficially or otherwise, any securities of the Issuer.
Item 5.	Interest in Securities of the Issuer
(a)	See the Reporting Persons section of this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.
(b)	See the Reporting Persons section of this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
(c)	Shares tendered in tender offer by the Issuer.
(d)	The funds and accounts advised by Saba Capital have the right to receive the dividends and proceeds of sales from the Common Shares.
(e)	Jul-09-2025
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Not Applicable.
Item 7.	Material to be Filed as Exhibits.
	Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Saba Capital Management, L.P.

Signature:	/s/ Michael D'Angelo
Name/Title:	General Counsel
Date:	07/11/2025

Boaz R. Weinstein

Signature:	/s/ Michael D'Angelo
Name/Title:	Authorized Signatory
Date:	07/11/2025

Saba Capital Management GP, LLC

Signature:	/s/ Michael D'Angelo
Name/Title:	Attorney-in-fact*
Date:	07/11/2025

Comments accompanying signature:

Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823

FAQ

Why did NanoVibronix (NAOV) adjourn its special meeting on 11 July 2025?

The meeting lacked a quorum, so no business could be conducted and it was adjourned.

When will the NanoVibronix special meeting reconvene?

It will reconvene virtually on 17 July 2025 at 10:00 a.m. ET.

Is the record date for voting on NAOV proposals changing?

No. The record date remains 16 May 2025.

What is the new proxy voting deadline for NAOV shareholders?

Registered shareholders must submit proxies by 11:59 p.m. ET on 16 July 2025.

Do previously submitted NAOV proxies remain valid?

Yes, proxies already deposited will be honored at the reconvened meeting.

Where can investors access the detailed proxy statement?

The Definitive Proxy Statement filed on 20 June 2025 is available free of charge on the SEC’s website and from the company.